Rapid detection and differentiation of Influenza A and B and Sars-Cov-2
Avidin has expanded the company’s Covid-19 molecular diagnostic portfolio with its PCR-based solution to detect and differentiate Sars-Cov-2, Influenza A, and Influenza B.
Avidin can simultaneously check for Covid-19 and Influenza infection from the same specimen by using its multi-diagnostic PCR solution with high specificity and sensitivity. The multi-diagnostic solution can quickly distinguish between the two diseases which have similar respiratory symptoms and a high transmission rate.
This solution can support the decision in vaccination programs because patients having either Sars-Cov-2, Influenza A, or Influenza B infection is not allowed to get an Influenza vaccination. Our PCR protocol can exclude both respiratory diseases from the same sample accelerating diagnosis.